Researcher, Department of Clinical Neuroscience and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
I am a researcher at the Department of Clinical Neuroscience and the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet. I obtained my PhD at Karolinska Institutet and completed postdoctoral fellowships at the University of Oxford and at Karolinska Institutet.
My research is mostly focused on pharmacoepidemiology. That is, I study the risks and benefits of common medications with a specific interest in psychiatric and behavioural outcomes such as depression, anxiety, suicide, overdoses, accidents, violence and other crimes. For this, I use Swedish pharmacy, healthcare, sociodemographic, crime and death registers, and I study nationwide cohorts of people who take different medications. I have previously published studies on the psychiatric and behavioural outcomes of antidepressants, nicotine replacement therapy, antiepileptic drugs, cholesterol-lowering medications, and medications for treating substance use disorders.
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight